共 107 条
[1]
Sinnaeve PR(2012)Stroke prevention in elderly patients with atrial fibrillation: challenges for anticoagulation J Intern Med 271 15-24
[2]
Brueckmann M(2014)Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study Circulation 129 837-847
[3]
Clemens A(2007)Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial Lancet 370 493-503
[4]
Chugh SS(2009)The net clinical benefit of warfarin anticoagulation in atrial fibrillation Ann Intern Med 151 297-305
[5]
Havmoeller R(2011)Risks of thromboembolism and bleeding with thromboprophylaxis in patients with atrial fibrillation: a net clinical benefit analysis using a ‘real world’ nationwide cohort study Thromb Haemost 106 739-749
[6]
Narayanan K(2012)Net clinical benefit of warfarin in patients with atrial fibrillation: a report from the Swedish atrial fibrillation cohort study Circulation 125 2298-2307
[7]
Mant J(2014)Net clinical benefit of warfarin therapy in elderly Chinese patients with atrial fibrillation Circ Arrhythm Electrophysiol 7 300-306
[8]
Hobbs FD(2006)Translating the results of randomized trials into clinical practice: the challenge of warfarin candidacy among hospitalized elderly patients with atrial fibrillation Stroke 37 1075-1080
[9]
Fletcher K(2011)Attitudes of physicians regarding anticoagulation for atrial fibrillation: a systematic review Age Ageing 40 675-683
[10]
Singer DE(2013)Current presentation and management of 7148 patients with atrial fibrillation in cardiology and internal medicine hospital centers: the ATA AF study Int J Cardiol 167 2895-2903